Reid M. Huber - 03 Jan 2023 Form 4/A - Amendment Insider Report for BELLICUM PHARMACEUTICALS, INC

Role
Director
Signature
/s/ Richard A. Fair, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
03 Jan 2023
Net transactions value
$0
Form type
4/A - Amendment
Filing time
20 Jan 2023, 13:24:51 UTC
Date Of Original Report
05 Jan 2023
Previous filing
02 Sep 2022
Next filing
08 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLCM Common Stock Options Exercise $0 +80,968 +123% $0.000000 146,951 03 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed to correct the mathematical error in the amount of securities acquired and the amount of securities beneficially owned following reported transaction on the original Form 4 filed with the SEC on January 5, 2023.